Diatech Pharmacogenetics is a European leader in molecular diagnostics and precision oncology, specializing in innovative assays and software for targeted cancer therapy and pharmacogenomics. Their portfolio features the EasyPGX® platform—a dry, ready-to-use qPCR system delivering rapid tumor and hematology biomarker results in under three hours—alongside Myriapod® NGS panels and on-premise bioinformatics for comprehensive genomic profiling.